Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of alzheimer's disease

Journal of Alzheimer's Disease

Volumn 29, Issue 3, 2012, Pages 615-628

  Moon, Minho ^a   Hong, Hyun Seok ^a   Nam, Dong Woo ^a   Baik, Sung Hoon ^a   Song, Hyundong ^a   Kook, Sun Young ^a   Kim, Yong Soo ^b   Lee, Jeewoo ^b   Mook Jung, Inhee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

5XFAD mice; Alzheimer's disease; amyloid plaque; calcium binding proteins; intraneuronal A ; pyroglutamate modified A

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; CELL PROTEIN; PARVALBUMIN; PYROGLUTAMIC ACID;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; IMMUNOREACTIVITY; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 84859383216     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111778     Document Type: Article

References (34)

1. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
2. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. (Pubitemid 36937044)
3. Christensen DZ, Bayer TA, Wirths O (2010) Intracellular Abeta triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease. Neurobiol Aging 31, 1153-1163.
4. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688. (Pubitemid 40320703)
5. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058. (Pubitemid 30365675)
6. Tomiyama T, Matsuyama S, Iso H, Umeda T, Takuma H, Ohnishi K, Ishibashi K, Teraoka R, Sakama N, Yamashita T, Nishitsuji K, Ito K, Shimada H, Lambert MP, Klein WL, Mori H (2010) A mouse model of amyloid beta oligomers: Their contribution to synaptic alteration, abnormal tau phosphory-lation, glial activation, and neuronal loss in vivo. J Neurosci 30, 4845-4856.
7. Friedrich RP, Tepper K, Ronicke R, Soom M, Westermann M, Reymann K, Kaether C, Fandrich M (2010) Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci USA 107, 1942-1947.
8. Hu X, Crick SL, Bu G, Frieden C, Pappu RV, Lee JM (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci USA 106, 20324-20329.
9. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysistoform amyloid plaquesinAlzheimer's disease. Histopathology 38, 120-134. (Pubitemid 32193626)
10. D'Andrea MR, Nagele RG (2010) Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis. Biotech Histochem 85, 133-147.
11. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140. (Pubitemid 44527407)
12. Saido TC, Iwatsubo T, Mann DM, Shimada H, Ihara Y, Kawashima S (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3 (pE), in senile plaques. Neuron 14, 457-466.
13. Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, Bohm G, Demuth HU (2006) On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45, 12393-12399. (Pubitemid 44583682)
14. Gunn AP, Masters CL, Cherny RA (2010) Pyroglutamate-Abeta: Role in the natural history of Alzheimer's disease. Int J Biochem Cell Biol 42, 1915-1918.
15. Schilling S, Zeitschel U, Hoffmann T, Heiser U, Francke M, Kehlen A, Holzer M, Hutter-Paier B, Prokesch M, Windisch M, Jagla W, Schlenzig D, Lindner C, Rudolph T, Reuter G, Cynis H, Montag D, Demuth HU, Rossner S (2008) Glu-taminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med 14, 1106-1111.
16. Cynis H, Scheel E, Saido TC, Schilling S, Demuth HU (2008) Amyloidogenic processingof amyloid precursor protein: Evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta. Biochemistry 47, 7405-7413. (Pubitemid 351991019)
17. Hartlage-Rubsamen M, Morawski M, Waniek A, Jager C, Zeitschel U, Koch B, Cynis H, Schilling S, Schliebs R, Demuth HU, Rossner S (2011) Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Abeta deposits in hippocampus via distinct cellular mechanisms. Acta Neuropathol 121, 705-719.
18. Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH (1991) Parvalbumin-immunoreactive neurons in the neo-cortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 50, 451-462.
19. Hof PR, Nimchinsky EA, Celio MR, Bouras C, Morrison JH (1993) Calretinin-immunoreactive neocortical interneu-rons are unaffected in Alzheimer's disease. Neurosci Lett 152, 145-148.
20. Greene JR, Radenahmad N, Wilcock GK, Neal JW, Pearson RC (2001) Accumulation of calbindin in cortical pyramidal cells with ageing; A putative protective mechanism which fails in Alzheimer's disease. Neuropathol Appl Neurobiol 27, 339-342. (Pubitemid 32990074)
21. Iritani S, Niizato K, Emson PC (2001) Relationship of cal-bindin D28K-immunoreactive cells and neuropathological changesinthe hippocampal formationofAlzheimer's disease. Neuropathology 21, 162-167. (Pubitemid 32947278)
22. Riascos D, de Leon D, Baker-Nigh A, Nicholas A, Yukhananov R, Bu J, Wu CK, Geula C (2011) Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease. Acta Neuropathol 122, 565-576.
23. Paxinos G, Franklin KBJ (2001) The mouse brain in stereo-taxic coordinates, Academic Press, San Diego.
24. Mostany R, Portera-Cailliau C (2008) A craniotomy surgery procedure for chronic brain imaging. J Vis Exp, pii: 680.
25. Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y, Hyman BT (2002) Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.J Neuropathol Exp Neurol 61, 797-805. (Pubitemid 35001352)
26. Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O (2012) Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging 33, 196.e29-e40.
27. Schlenzig D, Manhart S, Cinar Y, Kleinschmidt M, Hause G, Willbold D, Funke SA, Schilling S, Demuth HU (2009) Pyroglutamate formation influences solubility and amy-loidogenicity of amyloid peptides. Biochemistry 48, 7072-7078.
28. Saido TC (1998) Alzheimer's diseaseasproteolytic disorders: Anabolism and catabolism of beta-amyloid. Neurobiol Aging 19, S69-S75. (Pubitemid 28178942)
29. Glabe C (2001) Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 17, 137-145. (Pubitemid 33063518)
30. Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26, 1235-1244. (Pubitemid 41338539)
31. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21, 372-381. (Pubitemid 32107428)
32. Wirths O, Bethge T, Marcello A, Harmeier A, Jawhar S, Lucassen PJ, Multhaup G, Brody DL, Esparza T, Ingelsson M, Kalimo H, Lannfelt L, Bayer TA (2010) Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases. J Neural Transm 117, 85-96.
33. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: Cell-specific pathology isolates the hip-pocampal formation. Science 225, 1168-1170. (Pubitemid 14029099)
34. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.